"10.1371_journal.pone.0037239","plos one","2012-05-15T00:00:00Z","Ivaylo Gentschev; Marion Adelfinger; Rafael Josupeit; Stephan Rudolph; Klaas Ehrig; Ulrike Donat; Stephanie Weibel; Nanhai G Chen; Yong A Yu; Qian Zhang; Martin Heisig; Douglas Thamm; Jochen Stritzker; Amy MacNeill; Aladar A Szalay","Genelux Corporation, San Diego Science Center, San Diego, California, United States of America; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany; Rudolf Virchow Center for Experimental Biomedicine, University of Wuerzburg, Wuerzburg, Germany; Institute for Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany; Department of Radiation Oncology, Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America; Institut für Medizinische Strahlenkunde und Zellforschung (MSZ), University of Wuerzburg, Wuerzburg, Germany; Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America; Department of Pathobiology, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, United States of America","Conceived and designed the experiments: IG MA RJ SR SW AM JS AAS. Performed the experiments: IG MA RJ SR KE UD AM JS. Analyzed the data: IG MA SW NGC DT MH UD AM JS AAS. Contributed reagents/materials/analysis tools: NGC YAY QZ AM. Wrote the paper: IG AM AAS.","The authors have read the journals policy and have the following conflicts: IG QZ YAY NGC JS and AAS are employees and shareholders of Genelux Corporation. MA, KE and SW were supported by grants of Genelux Corporation. Sequences of the two Lister Vaccinia virus strains (LIVP1.1.1 and LIVP5.1.1.) tested in this study are subject of the patent application ‘Clonal strains of attenuated vaccinia viruses and methods of use thereof (U.S. Application No. 61/517,297)’. There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors (http://www.plosone.org/static/policies.action#sharing). The authors do not have any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products, etc. The title and the permit number for the patent are: ‘ Clonal strains of attenuated vaccinia viruses and methods of use thereof (U.S. Application No. 61/517,297)’.","2012","05","Ivaylo Gentschev","IG",15,TRUE,8,8,10,3,TRUE,TRUE,FALSE,0,NA,FALSE
